The Gallay lab recently demonstrated that mice lacking CypB, unlike those lacking CypA, were protected from non-alcoholic steatohepatitis (NASH) in both dietary and chemically induced models. Here, PPIA is linked to metabolic dysfunction-associated steatohepatitis.